Terug
52
Dagbereik
€ 2,35
€ 3,16
52-Weeksbereik
€ 0,16
€ 3,33
Volume
2.127
50D / 200D Gem.
€ 2,71
/
€ 1,37
Vorige Slotkoers
€ 3,16
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -60,4 | 0,3 |
| P/B | 28,3 | 2,9 |
| ROE % | -44,5 | 3,7 |
| Net Margin % | -513,7 | 3,8 |
| Rev Growth 5Y % | 127,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,02
€ 0,01 – € 0,03
|
110 M | 1 |
| FY2028 |
-€ 0,01
-€ 0,01 – € 0,00
|
65 M | 1 |
| FY2027 |
-€ 0,04
-€ 0,07 – -€ 0,03
|
33 M | 1 |
Belangrijkste Punten
Revenue grew 127,90% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -34,56M
PEG of 0,07 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 35,96%
Capital efficient — spends only 1,47% of revenue on capex
Groei
Revenue Growth (5Y)
127,90%
Revenue (1Y)91,94%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-44,49%
ROIC-31,97%
Net Margin-513,72%
Op. Margin-499,20%
Veiligheid
Debt / Equity
0,07
Current Ratio0,89
Interest Coverage0,00
Waardering
P/E Ratio
-60,36
P/B Ratio28,26
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 91,94% | Revenue Growth (3Y) | 185,41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 127,90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5,85M | Net Income (TTM) | -30,07M |
| ROE | -44,49% | ROA | -31,72% |
| Gross Margin | 92,07% | Operating Margin | -499,20% |
| Net Margin | -513,72% | Free Cash Flow (TTM) | -34,56M |
| ROIC | -31,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 0,89 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -60,36 | P/B Ratio | 28,26 |
| P/S Ratio | 310,07 | PEG Ratio | 0,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,81B | Enterprise Value | 1,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,85M | 3,05M | 718.581,0 | 1,05M | 216.978,0 |
| Net Income | -30,07M | -35,98M | -31,46M | -24,59M | -21,42M |
| EPS (Diluted) | -0,14 | -0,10 | -0,10 | -0,08 | -0,08 |
| Gross Profit | 5,39M | 2,81M | -24,28M | 280.617,0 | 125.125,0 |
| Operating Income | -29,22M | -46,61M | -30,65M | -22,20M | -13,69M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94,81M | 120,02M | 92,92M | 74,31M | 92,64M |
| Total Liabilities | 30,58M | 49,09M | 21,46M | 14,80M | 9,28M |
| Shareholders' Equity | 64,24M | 70,93M | 71,46M | 59,51M | 83,36M |
| Total Debt | 4,31M | 5,12M | 5,14M | 6,24M | 1,69M |
| Cash & Equivalents | 6,88M | 30,61M | 69,58M | 51,11M | 80,88M |
| Current Assets | 17,06M | 39,05M | 78,54M | 58,85M | 85,85M |
| Current Liabilities | 19,25M | 21,89M | 17,07M | 9,56M | 8,17M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#51 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026